The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer
about
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@ast
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@en
type
label
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@ast
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@en
prefLabel
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@ast
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@en
P2093
P2860
P50
P1433
P1476
The Splicing Efficiency of Act ...... notype and Frequency in Cancer
@en
P2093
Anne-Mette Hartung
David A Stevenson
Henriette Skovgaard Andersen
Inaki E Uriz
Jeanne Mari V Bang
John C Carey
Karen Kristjansdottir
Steven F Dobrowolski
Ulrika S S Petersen
P2860
P304
P356
10.1371/JOURNAL.PGEN.1006039
P50
P577
2016-05-19T00:00:00Z